Literature DB >> 24641716

An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues.

Jeong Eun Kim, Jin Sue Jeon.   

Abstract

Moyamoya disease (MMD) is characterized by a chronic progressive steno-occlusive disease at the distal portion of the internal carotid artery (ICA) with abnormal Moyamoya vessel (MMV) development without associated diseases. Recent advances in radiologic tests have increased the number of MMD patients. Beyond detection improvement by magnetic resonance angiography (MRA) or cerebral angiography, predicting factors for disease severity, future hemorrhage, clinical outcome, post-op complications, and technical advances in assessing cerebral hemodynamics have been increasingly reported. Although treatment of pediatric MMD is well established, controversy remains over the treatment in adult patients. In particular, there are debates over the disease entity of adult MMD, contralateral progression in adult unilateral MMD, treatment strategy for asymptomatic adult MMD, and the association of MMD with thyroid disease. The purpose of this review is to provide an update on the diagnosis and treatment of adult MMD while addressing controversial issues.

Entities:  

Keywords:  Hemorrhage,; Ischemic,; Moyamoya disease,; Revascularization

Mesh:

Year:  2014        PMID: 24641716     DOI: 10.1179/1743132814Y.0000000351

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  17 in total

Review 1.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

2.  Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

Authors:  Junsheng Li; Peicong Ge; Qian Zhang; Fa Lin; Rong Wang; Yan Zhang; Dong Zhang; Wen Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2021-01-27       Impact factor: 3.042

3.  Changes in Brain Functional Network Connectivity in Adult Moyamoya Diseases.

Authors:  Gaoxing Zheng; Yu Lei; Yuzhu Li; Wei Zhang; Jiabin Su; Xiaoying Qi; Liang Chen; Xin Zhang; Yuxiang Gu; Yuguo Yu; Ying Mao
Journal:  Cogn Neurodyn       Date:  2021-02-07       Impact factor: 3.473

Review 4.  [Juvenile stroke - what is important?]

Authors:  M Fischer; B Eckert; J Röther
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

Review 5.  Diagnosis of moyamoya disease: international standard and regional differences.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 6.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

7.  1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.

Authors:  Jin Pyeong Jeon; Taeho Yun; Xing Jin; Won-Sang Cho; Young-Je Son; Jae Seung Bang; Hyun-Seung Kang; Chang Wan Oh; Jeong Eun Kim; Sunghyouk Park
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 8.  Progress on Complications of Direct Bypass for Moyamoya Disease.

Authors:  Jinlu Yu; Lei Shi; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

Review 9.  A Recent Update of Clinical and Research Topics Concerning Adult Moyamoya Disease.

Authors:  Jin Pyeong Jeon; Jeong Eun Kim
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

10.  Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study).

Authors:  Daisuke Onozuka; Akihito Hagihara; Kunihiro Nishimura; Akiko Kada; Jyoji Nakagawara; Kuniaki Ogasawara; Junichi Ono; Yoshiaki Shiokawa; Toru Aruga; Shigeru Miyachi; Izumi Nagata; Kazunori Toyoda; Shinya Matsuda; Akifumi Suzuki; Hiroharu Kataoka; Fumiaki Nakamura; Satoru Kamitani; Ataru Nishimura; Ryota Kurogi; Tetsuro Sayama; Koji Iihara
Journal:  BMJ Open       Date:  2016-03-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.